Total and not bevacizumab-bound vascular endothelial growth factor as potential predictive factors to bevacizumab-based chemotherapy in colorectal cancer

AIM: To identify suitable biomarkers of response to bevacizumab (BV) - it remains an open question. The measurement of serum vascular endothelial growth factor (VEGF) has been proposed as a predictive factor for this drug, even if literature data are contradictory. METHODS: We prospectively evaluate...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:World J Gastroenterol
Autors principals: Azzariti, Amalia, Porcelli, Letizia, Brunetti, Oronzo, Del Re, Marzia, Longo, Vito, Nardulli, Patrizia, Signorile, Michele, Xu, Jian-Ming, Calabrese, Angela, Quatrale, Anna Elisa, Maiello, Evaristo, Lorusso, Vito, Silvestris, Nicola
Format: Artigo
Idioma:Inglês
Publicat: Baishideng Publishing Group Inc 2016
Matèries:
Prospective Study
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4945987/
https://ncbi.nlm.nih.gov/pubmed/27468218
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v22.i27.6287
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars